Nxstage Medical (NXTM) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
NxStage Reports Fourth Quarter and Full-Year 2016 Financial Results
February 28, 2017 8:05 AM ESTLAWRENCE, Mass., Feb. 28, 2017 /PRNewswire/ --
Highlights:
Full-Year Revenue Increases to $366 million, up 9% from 2015 Full-Year Home Revenue Increases to $209 million, up over 14% from 2015 Full-Year Operating Income from Products Business More than Doubles to $23 million Outlook for 2017 Includes Strong Revenue Growth and Total Company Profitability Company Continues to Target Introduction of Peritoneal Dialysis System at End of 2017